Only one basic product with variants? Currently, all products beyond AG200-15 are on hold. Depending on the outcome of the initial Phase II clinical trial of the Small Patch (SmP) program, additional design and planning may be required for SmP pipeline products. https://agiletherapeutics.com/product-pipeline/